Large Molecule Drug Development for the Treatment of Myasthenia Gravis

Time: 9:00 am
day: Day Two

Details:

  • Showcasing disease-specific proteins as a technology for antigen delivery
  • Discussing applications in two different indications
  • Sharing thoughts on translation to the clinic

Speakers: